Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation
Clinical trial NCT03856697 · UNKNOWN
Trial details
- NCT number
- NCT03856697
- Sponsor
- Hangzhou ACEA Pharmaceutical Research Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2022-03-01
- Enrollment
- 406
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.